Glenmede Trust CO Na Nkarta, Inc. Transaction History
Glenmede Trust CO Na
- $18.2 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding NKTX
# of Institutions
114Shares Held
59.1MCall Options Held
0Put Options Held
67.1K-
Ra Capital Management, L.P. Boston, MA10.8MShares$22.5 Million0.39% of portfolio
-
Tang Capital Management LLC San Diego, CA7.06MShares$14.7 Million0.7% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$8.44 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$7.84 Million2.69% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$7.42 Million0.49% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $101M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...